Olalekan Chris Akinsulie, Sinem Ulusan, Ibrahim Idris, Sammuel Shahzad, James Okon, Chizaram Ukauwa, Moyinoluwa Joshua Oladoye, Victor Ayodele Aliyu, Charles Egede Ugwu, Toyin Florence Ayandokun, Roberta Koku, Jesuferanmi Mary Akinsulie, Muhammad Ipoola Adeyemi, Charity Chinonso Ugwu, Lilian Chizobam Ugorji
Antibodies are highly specialized glycoproteins produced by B cells in response to antigenic stimulation. They are a major component of the adaptive immune system and play a key role in host defenses by detecting, neutralizing, and eliminating foreign antigens. Over the years, their roles have transcended mere immune biomarkers due to their unique specificity, affinity maturation, and structural versatility, making them indispensable tools in biomedical research, including vaccine design, therapeutic development, and diagnostics. In this work, we examine the structural and functional basis of antibody bioactivity while highlighting key engineering strategies, including Fc modification, glycosylation engineering, and the development of novel antibody formats. We also considered the application of engineered antibodies in infectious disease and cancer prevention and treatment, focusing on current challenges, and proposing emerging directions that position antibody engineering as a transformative approach in future biomedical research and innovation.